ABOUT
About Ipamorelin Safe
An independent reading of the ipamorelin literature — forward-looking about the science, honest about the gaps.
What this site is
Ipamorelin Safe is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on ipamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site exists because ipamorelin sits at an unusual intersection: a genuinely elegant piece of pharmacology — the first selective growth hormone secretagogue [1] — wrapped in marketing that often outruns the evidence. Our aim is to keep the two apart: to celebrate the science that is real and reproducible, and to be candid about the human evidence that is thin and the safety questions that remain open.
What 'safe' means in our name
The word safe in this domain names a question, not a promise. Ipamorelin's selectivity record — releasing growth hormone without raising cortisol or prolactin — is a real and favourable safety feature relative to older peptides [1]. But a favourable selectivity profile is not the same as a complete safety profile: there is no long-term human safety data for ipamorelin, its one efficacy trial did not succeed [3], and a related compound showed cardiac toxicity in rodents [6]. We treat 'safe' as something to investigate openly and report honestly — never as a verdict we are selling. If you came here for reassurance, you will instead find the evidence, with its limits intact.
How we work, and what the name means
Every quantitative claim on this site is tied to a numbered citation in our Ipamorelin references, drawn from PubMed-indexed journals, clinical-trial records, and regulatory sources. We summarise what studies measured, in the species and setting they measured it, and we do not extrapolate findings into dosing advice.
The name Ipamorelin Safe is editorial framing — the position this publisher takes toward the literature, foregrounding the safety question — not a claim that we offer medical services, screening, or any assurance about using the compound. We are a reading desk for the research, nothing more, and that distinction is one we hold to deliberately.